{"id":"W776120597","doi":"10.1155/2013/170546","title":"In a ‘Real-World’, Clinic-Based Community Setting, Sorafenib Dose of 400 mg/day is as Effective as Standard Dose of 800 mg/day in Patients with Advanced Hepatocellular Carcimona, with Better Tolerance and Similar Survival","year":2013,"lang":"en","type":"article","venue":"Canadian Journal of Gastroenterology","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Sorafenib; Medicine; Hepatocellular carcinoma; Adverse effect; Internal medicine; Incidence (geometry); Retrospective cohort study; Liver cancer; Cancer; Gastroenterology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":true,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005636726,0.0001065689,0.0002788746,0.0001843404,0.0002338991,0.0003033497,0.0001735314,0.0002210995,0.0023303],"category_scores_gemma":[0.002216336,0.0001102237,0.0001283317,0.0003997358,0.0002348553,0.0002161499,0.000114578,0.0002433289,0.0002796926],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005944851,"about_ca_system_score_gemma":0.0005253928,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003352325,"about_ca_topic_score_gemma":0.009724503,"domain_scores_codex":[0.9995226,0.0001955134,0.0000463395,0.00008356643,0.0001088879,0.00004306606],"domain_scores_gemma":[0.9988798,0.0002628765,0.0004950548,0.00004156641,0.0001496941,0.0001710107],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.003828339,0.001079959,0.8998637,0.0003607375,0.0002613048,0.0006793709,0.0002419089,0.0004932871,0.007866934,0.00004654174,0.003446588,0.08183143],"study_design_scores_gemma":[0.0003884481,0.002663779,0.988159,0.00004139082,0.00009092083,0.00381915,0.0002350439,0.0005238946,0.0008760528,0.00003391329,0.003156899,0.0000116934],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9957563,0.001824455,0.0001852384,0.000243137,0.00001268974,0.00003655811,0.0001474161,0.00001450486,0.001779666],"genre_scores_gemma":[0.9987955,0.0005065323,0.0002766816,0.0001215853,0.00002140728,0.000009400704,0.0001732011,0.000002137537,0.00009356632],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003352325,"threshold_uncertainty_score":0.007795632,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01393274766810664,"score_gpt":0.2390487774270065,"score_spread":0.2251160297588999,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}